6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis

Inclusion Criteria:

• Patient over 18 years of age,

• Patient with osteoarthritis of the hip. The diagnosis is based on the followingcriteria:

• Treated hip pain: Oxford score ≥ 21/60,

• Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no morethan 6 months before the inclusion visit),

• Symptoms related to osteoarthritis of the hip for at least 2 months,

• Failure of treatments (i.e., inadequate or ineffective response to analgesics and/orNSAIDs or intolerance to NSAIDs or low-grade opioids (leaving an OXFORD score ≥ 21/60),

• Informed consent form signed by the patient,

• The patient has never had a visco supplement injection or corticosteroid injectionin the hip to be treated (or more than 6 months old).

Exclusion Criteria:

• Pregnancy,

• Participation in another clinical trial,

• Skin lesion near the injection site,

• Recent or old infection of the affected joint,

• Patient with a programmed arthroplasty,

• Patient with a pathology that makes decision-making impossible,

• The patient must not have undergone non-prosthetic hip-conserving surgery such asosteotomy or arthroscopy less than 12 months old.